Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Go back to Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs| Bank of Commerce (NASDAQ: ONC) | Delayed: 369.43 +6.92 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $362.51 | 52 Week High | $0.35 | |||
| Open | $364.00 | 52 Week Low | $0.35 | |||
| Day High | $369.50 | P/E | N/A | |||
| Day Low | $361.14 | EPS | $0.00 | |||
| Volume | 264,976 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.85 +0.03 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.82 | 52 Week High | $1.37 | |||
| Open | $0.82 | 52 Week Low | $0.24 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.82 | EPS | $0.00 | |||
| Volume | 592,890 | |||||
